Pictet Asset Management (Switzerland)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $87.9M | Sell |
931,625
-62,206
| -6% | -$5.87M | 0.1% | 209 |
|
|
2023
Q1 | $82.2M | Buy |
993,831
+47,982
| +5% | +$3.97M | 0.1% | 222 |
|
|
2022
Q4 | $70.6M | Buy |
945,849
+36,069
| +4% | +$2.69M | 0.1% | 227 |
|
|
2022
Q3 | $75.2M | Buy |
909,780
+31,440
| +4% | +$2.6M | 0.11% | 219 |
|
|
2022
Q2 | $83.5M | Sell |
878,340
-26,339
| -3% | -$2.5M | 0.12% | 214 |
|
|
2022
Q1 | $106M | Sell |
904,679
-65,900
| -7% | -$7.76M | 0.12% | 208 |
|
|
2021
Q4 | $126M | Buy |
970,579
+82,274
| +9% | +$10.7M | 0.13% | 198 |
|
|
2021
Q3 | $101M | Buy |
+888,305
| New | +$101M | 0.11% | 224 |
|